Printer Friendly

Medinet, Two Medical Institutions Jointly Launch Clinical Studies of Gamma-delta T Cell Therapy for Multiple Myeloma.

Tokyo, Japan, Dec 7, 2005 - (JCN) - Japanese contract research organization (CRO) Medinet has signed a joint research agreement with two medical institutions, the Japanese Red Cross Medical Center and the Shin-Yokohama Medical Clinic.

The three partners will jointly undertake through March 2006 clinical studies of lymphokine-activated killer cell therapy using gamma-delta T cells. Specifically, they aim to verify the safety and validity of cell therapy in treating multiple myeloma, a type of blood cancer that develops anemia, renal damage, bone pain and fracture, and hypercalcemia.

Medinet will provide raw data on the therapy to the institutions while analyzing results obtained from the clinical studies.

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Dec 9, 2005
Previous Article:Toshiba Develops MEMS-based Cell Manipulation Method.
Next Article:Rohm and Haas Japan Introduces New Rheology Modifier ACULYN 38.

Related Articles
Silicone gel stimulates tumors in mice.
Tea time for T cells.
Old and new drugs may fight myeloma.
Nonsecretory multiple myeloma.
Multiple myeloma in a patient with hoarseness, dysphagia, aspiration, and cervical lymphadenopathy.
Medinet to Support University of Tokyo Hospital's 22nd Century Medical Center Project for Immune Cell Therapy.
Medinet, University of Tokyo Hospital Jointly Undertake Animal Experiments for Immune Cell Therapy.
MEDINET, Yokohama City University, Shin-Yokohama Medical Clinic Jointly Launch Clinical Study of Immune Cell Therapy for Pancreatic Cancer.
Medinet, University of Tokyo, Shin-Yokohama Medical Clinic Jointly Launch Clinical Studies of Activated Self Gamma-delta T Cell Therapy for Non-Small...
Fragile bones in a young male.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters